Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Italian cheap trick allowing unapproved drugs is 'dangerous attack on innovation'

This article was originally published in Scrip

Executive Summary

Draft legislation proposed by the Italian Ministry of Health contains "a very dangerous attack on the foundation of innovative drugs", Riccardo Palmisano, executive vice-president of the Italian biotech industry association Assobiotec, has warned. Dr Palmisano told Scrip that he was concerned about a "misuse of the philosophy" of a piece of legislation designed to allow patients with rare and orphan diseases to access yet-to-be authorised medicines, where no other therapies were available.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts